Concepedia

Serum IL-33 as a Diagnostic and Prognostic Marker in Non-small Cell Lung Cancer

HU Liang-an, Yu Fu, Danni Zhang, Jie Zhang

Asian Pacific Journal of Cancer Prevention · 2013 · 105 citations · 10 references

DOIFull text

Open access

Abstract

IL-33 is a promising potential diagnostic and prognostic marker in NSCLC, independent of the therapeutic intervention.

References

10

Cancer Statistics, 2010

Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text

IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines

Jochen Schmitz, Alexander M. Owyang, Elizabeth R. Oldham et al. · Immunity · 2005 · 3.6K citations · Full text

, , +7

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor<i>in vivo</i>

Virginie Carrière, Lucie Roussel, Nathalie Ortéga et al. · Proceedings of the National Academy of Sciences · 2006 · 938 citations · Full text

Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production

Yeon-Sook Choi, Hyun-Jung Choi, Jeong‐Ki Min et al. · Blood · 2009 · 292 citations · Full text

Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory Activation

Axel M. Küchler, Jürgen Pollheimer, Johanna Balogh et al. · American Journal Of Pathology · 2008 · 213 citations · Full text

, , +8